HIKMA Pharmaceuticals PLC — Director's Dealing 2019

Feb 11, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6285P

Hikma Pharmaceuticals Plc

11 February 2019

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.76%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,800,000
d)	Aggregated information	Aggregated volume: 1,800,000 Price: £0.00p
e)	Date of the transaction	7 February 2019
f)	Place of the transaction	Amman

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,800,000
d)	Aggregated information	Aggregated volume: 1,800,000 Price: £0.00p
e)	Date of the transaction	7 February 2019
f)	Place of the transaction	Amman

Mohammed 'Ali' Al-Husry

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mohammed 'Ali' Al-Husry
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.05%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 1,800,000
d)	Aggregated information	Aggregated volume: 1,800,000 Price: £0.00p
e)	Date of the transaction	7 February 2019
f)	Place of the transaction	Amman

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBGGDDRGBBGCB